Gadolinium Cardiovascular Magnetic Resonance Predicts Reversible Myocardial Dysfunction and Remodeling in Patients With Heart Failure Undergoing β-Blocker Therapy

Circulation

Volumn 108, Issue 16, 2003, Pages 1945-1953

  Bello, David ^a   Shah, Dipan J ^b   Farah, George M ^a   Di Luzio, Silvia ^a   Parker, Michele ^b   Johnson, Maryl R ^a   Cotts, William G ^a   Klocke, Francis J ^a   Bonow, Robert O ^a   Judd, Robert M ^b   Gheorghiade, Mihai ^a   Kim, Raymond J ^b,c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cardiomyopathy; Heart failure; Magnetic resonance imaging; Receptors, adrenergic, beta

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GADOTERIDOL; DIAGNOSTIC AGENT; GADOLINIUM; HETEROCYCLIC COMPOUND; ORGANOMETALLIC COMPOUND;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE WALL MOTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE CONTRACTILITY; HEART VENTRICLE REMODELING; HUMAN; MALE; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCAR FORMATION; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONVALESCENCE; DRUG EFFECT; HEART CONTRACTION; HEART STROKE VOLUME; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; SCAR; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; AGED; CICATRIX; GADOLINIUM; HEART FAILURE, CONGESTIVE; HETEROCYCLIC COMPOUNDS; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL CONTRACTION; ORGANOMETALLIC COMPOUNDS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 0142023855     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000095029.57483.60     Document Type: Article

References (25)

1. The Cardiac Insufficiency Bisoprolol Study II: a randomised trial. Lancet. 1999;353:9-13.
2. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure. Lancet. 1999; 353:2001-2007.
3. Packer M, Coats AJ, Fowler MB, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001;344:1651-1658.
4. Hunt HA, Baker DW, Chin MH, et al, ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult. Circulation. 2001;104:2996-3007.
5. Lechat P, Escolano S, Golmard JL, et al. Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency BIsoprolol Study. Circulation. 1997;96:2197-2205.
6. Bristow MR, Gilbert EM, Abraham WT, et al. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators. Circulation. 1996;94:2807-2816.
7. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med. 2001;344:1659-1667.
8. Cleland JG, Pennell DJ, Ray SG, et al. Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure: the CHRISTMAS trial. Lancet. 2003;362:14-21.
9. Wu E, Judd RM, Vargas JD, et al. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet. 2001;357:21-28.
10. Simonetti OP, Kim RJ, Fieno DS, et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology. 2001; 218:215-223.
11. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343:1445-1453.
12. Corya B, Feigenbaum H, Rasmussen S, et al. Echocardiographic features of congestive cardiomyopathy compared with normal subjects and patients with coronary artery disease. Circulation. 1974;49:1153-1159.
13. Rose GA, World Health Organization. Cardiovascular survey methods. Monograph series (World Health Organization); Geneva: World Health Organization; 1982:178.
14. S-PLUS 2000 Guide to Statistics: Volume 1. Seattle, Wash: Data Analysis Products Division, Mathsoft; 1999.
15. Myocardial infarction redefined: a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J, 2000; 21:1502-1513.
16. Bristow MR, O'Connell JB, Gilbert EM, et al. Dose-response of chronic β-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Bucindolol Investigators. Circulation. 1994; 89:1632-1642.
17. Lechat P, Packer M, Chalon S, et al, Clinical effects of β-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials. Circulation, 1998;98:1184-1191.
18. Lowes BD, Gilbert EM, Abraham WT, et al. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. N Engl J Med. 2002;346:1357-1365.
19. Hall SA, Cigarroa CG, Marcoux L, et al. Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with beta-adrenergic blockade. J Am Coll Cardiol. 1995;25:1154-1161.
20. Eichhorn EJ, Bristow MR. Medical therapy can improve the biological properties of the chronically failing heart: a new era in the treatment of heart failure. Circulation. 1996;94:2285-2296.
21. Yaoita H, Sakabe A, Maehara K, et al. Different effects of carvedilol, metoprolol, and propranolol on left ventricular remodeling after coronary stenosis or after permanent coronary occlusion in rats. Circulation. 2002; 105:975-980.
22. Packer M, Antonopoulos GV, Berlin JA, et al. Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: results of a meta-analysis. Am Heart J. 2001;141:899-907.
23. Schuster EH, Bulkley BH. Ischemic cardiomyopathy: a clinicopathologic study of fourteen patients. Am Heart J. 1980;100:506-512.
24. Roberts WC, Siegel RJ, McManus BM. Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients. Am J Cardiol. 1987;60: 1340-1355.
25. Uretsky BF, Thygesen K, Armstrong PW, et al. Acute coronary findings at autopsy in heart failure patients with sudden death: results from the Assessment of Treatment with Lisinopril and Survival (ATLAS) trial. Circulation. 2000;102:611-616.